Maestros Mediline Systems
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Key Insights
Weaknesses
3- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -57.8% over past five years.
- Company has high debtors of 1,251 days.
Technical Indicators
Oscillators
Bullish
Overall
Bearish
Moving Averages
Bearish
Growth Rate
change over 1 year
change over 1 year
Quarterly Results
| Particulars | Jun 2013 | Sep 2013 | Dec 2013 | Jun 2014 | Sep 2014 |
|---|---|---|---|---|---|
| Sales | 3.44 | 1.97 | 0.26 | 1.09 | 1.07 |
| Expenses | 4.41 | 0.05 | 0.36 | 0.58 | 1.76 |
| Operating Profit | -0.97 | 1.92 | -0.1 | 0.51 | -0.69 |
| OPM % | -28.2% | 97.46% | -38.46% | 46.79% | -64.49% |
| Other Income | 0 | 0 | 0.02 | 0 | 0 |
| Interest | 0.18 | 0.01 | 0 | 0 | 0.01 |
| Depreciation | 0.48 | 0.51 | 0.48 | 0.18 | 0.19 |
| PBT | -1.63 | 1.4 | -0.56 | 0.33 | -0.89 |
| Tax % | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -1.63 | 1.4 | -0.57 | 0.32 | -0.89 |
| EPS (₹) | -3.7 | 3.18 | -1.3 | 0.73 | -2.02 |
Profit & Loss
| Particulars | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 33.81 | 29.23 | 30.05 | 41.78 | 42.4 | 21.75 | 7.02 | 4.23 | 0.56 |
| Expenses | 30.28 | 25.66 | 26.06 | 33.48 | 34.79 | 31.93 | 20.46 | 25.74 | 2.99 |
| Operating Profit | 3.53 | 3.57 | 3.99 | 8.3 | 7.61 | -10.18 | -13.44 | -21.51 | -2.43 |
| OPM % | 10.44% | 12.21% | 13.28% | 19.87% | 17.95% | -46.8% | -191.45% | -508.51% | -433.93% |
| Other Income | 0.27 | 0.59 | 0.94 | 0.8 | 0.23 | 0.76 | -0.88 | 0.04 | 0.14 |
| Interest | 1.59 | 1.84 | 2.39 | 2.95 | 4.04 | 5.38 | 0.37 | 0.03 | 0.02 |
| Depreciation | 1.27 | 1.26 | 1.76 | 2.37 | 1.86 | 2.06 | 1 | 0.79 | 0.7 |
| PBT | 0.94 | 1.06 | 0.78 | 3.78 | 1.94 | -16.86 | -15.69 | -22.29 | -3.01 |
| Tax % | 44.68% | 75.47% | 23.08% | 2.91% | -7.73% | -7.41% | 0% | 0% | 0% |
| Net Profit | 0.52 | 0.26 | 0.6 | 3.67 | 2.08 | -15.61 | -15.69 | -22.29 | -3 |
| EPS (₹) | — | 0.59 | 1.36 | 8.34 | 4.73 | -35.48 | -35.66 | -50.66 | -6.82 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.55 | 4.42 | 4.37 | 4.37 | 4.37 | 4.37 | 4.37 | 4.37 | 4.37 |
| Reserves | 30.89 | 30.77 | 31.23 | 34.97 | 13.15 | -2.56 | -18.39 | -41.46 | -44.46 |
| Borrowings | 4.39 | 7.79 | 7.5 | 11.72 | 38.96 | 49.68 | 51.06 | 54.1 | 54.37 |
| Other Liabilities | 18.6 | 23.58 | 26 | 24.39 | 21.25 | 22.43 | 20.16 | 5.91 | 7.79 |
| Total Liabilities | 58.43 | 66.56 | 69.1 | 75.45 | 77.73 | 73.92 | 57.2 | 22.92 | 22.07 |
| Fixed Assets | 23.17 | 28.04 | 28.19 | 31.14 | 15.62 | 15.28 | 13.45 | 11.89 | 11.19 |
| CWIP | 0.18 | 0.36 | 0 | 0 | 7.4 | 0 | 0 | 0 | 0 |
| Investments | 3.89 | 0.31 | 0.31 | 0.81 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 31.19 | 37.85 | 40.6 | 43.5 | 54.71 | 58.64 | 43.75 | 11.03 | 10.88 |
| Total Assets | 58.43 | 66.56 | 69.1 | 75.45 | 77.73 | 73.92 | 57.2 | 22.92 | 22.07 |
Cash Flow
| Particulars | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Operating | 12.76 | 7.28 | 3.24 | 2.84 | -7.5 | -6.77 | -0.45 | -0.27 | 0.09 |
| Investing | -4.82 | -2.58 | -1.55 | -5.98 | -14.89 | 1.08 | 0.94 | -0.38 | 0.05 |
| Financing | -7.48 | 0.98 | -2.88 | 1.28 | 23.8 | 2.16 | -0.26 | -0.14 | 0.04 |
| Net Cash Flow | 0.46 | 5.68 | -1.19 | -1.86 | 1.41 | -3.53 | 0.22 | -0.79 | 0.18 |
| Free Cash Flow | 12.78 | 7.28 | 3.24 | 2.86 | -22.48 | -6.77 | -0.45 | -0.27 | 0.09 |
| CFO/OP | 361 | 204 | 81 | 34 | -99 | 66 | 3 | 1 | -4 |
Ratios
| Particulars | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 152 | 138 | 152 | 127 | 214 | 393 | 1,302 | 225 | 1,251 |
| Inventory Days | 159 | 236 | 273 | 241 | 262 | 241 | 66.54 | 40.16 | 69.3 |
| Days Payable | 115 | 180 | 240 | 154 | 209 | 180 | 257 | 129 | 1,686 |
| Cash Conversion Cycle | 196 | 193 | 186 | 214 | 268 | 454 | 1,112 | 136 | -366 |
| Working Capital Days | 138 | 120 | 139 | 163 | 259 | 579 | 1,132 | 319 | 1,004 |
| ROCE % | — | 7% | 7.37% | 14.32% | 11.12% | -21.27% | -32.62% | -82.37% | -19.11% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Maestros Mediline Systems insights
57 extracted metrics + investor summaries across FY02–FY16.
Documents
Frequently Asked Questions about Maestros Mediline Systems
What does Maestros Mediline Systems Ltd do?
Where is Maestros Mediline Systems Ltd (501209) listed?
Company Information
Maestros is India's leading medical diagnostic equipment and services organizations, which focuses on empowering medical professionals and institutions, that treat cardiac, gynecology and critical care patients across the country.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/501209.md for Maestros Mediline Systems Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.